These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 16547815)
41. Recent medicinal chemistry of the histamine H3 receptor. Letavic MA; Barbier AJ; Dvorak CA; Carruthers NI Prog Med Chem; 2006; 44():181-206. PubMed ID: 16697898 [No Abstract] [Full Text] [Related]
42. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand. Airaksinen AJ; Jablonowski JA; van der Mey M; Barbier AJ; Klok RP; Verbeek J; Schuit R; Herscheid JD; Leysen JE; Carruthers NI; Lammertsma AA; Windhorst AD Nucl Med Biol; 2006 Aug; 33(6):801-10. PubMed ID: 16934699 [TBL] [Abstract][Full Text] [Related]
43. Histamine H3 and H4 receptors as novel drug targets. Tiligada E; Zampeli E; Sander K; Stark H Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107 [TBL] [Abstract][Full Text] [Related]
44. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists. Célanire S; Wijtmans M; Christophe B; Collart P; de Esch I; Dassesse D; Delaunoy C; Denonne F; Durieu V; Gelens E; Gillard M; Lallemand B; Lamberty Y; Lebon F; Nicolas JM; Quéré L; Snip E; Vanbellinghen A; Van Houtvin N; Verbois V; Timmerman H; Talaga P; Leurs R; Provins L ChemMedChem; 2009 Jul; 4(7):1063-8. PubMed ID: 19405064 [TBL] [Abstract][Full Text] [Related]
45. Fluorescent benzofuran histamine H(3) receptor antagonists with sub-nanomolar potency. Cowart M; Gfesser GA; Bhatia K; Esser R; Sun M; Miller TR; Krueger K; Witte D; Esbenshade TA; Hancock AA Inflamm Res; 2006 Apr; 55 Suppl 1():S47-8. PubMed ID: 16705379 [No Abstract] [Full Text] [Related]
46. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists. Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422 [TBL] [Abstract][Full Text] [Related]
47. Constitutive activity of the histamine H3 receptor. Arrang JM; Morisset S; Gbahou F Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125 [TBL] [Abstract][Full Text] [Related]
48. Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human H3-receptor. Peschke B; Bak S; Hohlweg R; Nielsen R; Viuff D; Rimvall K Bioorg Med Chem Lett; 2006 Jun; 16(12):3162-5. PubMed ID: 16616493 [TBL] [Abstract][Full Text] [Related]
49. Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines. Dvorak CA; Apodaca R; Xiao W; Jablonowski JA; Bonaventure P; Dugovic C; Shelton J; Lord B; Miller K; Dvorak LK; Lovenberg TW; Carruthers NI Eur J Med Chem; 2009 Oct; 44(10):4098-106. PubMed ID: 19524331 [TBL] [Abstract][Full Text] [Related]
50. Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores. Keith JM; Barbier AJ; Wilson SJ; Miller K; Boggs JD; Fraser IC; Mazur C; Lovenberg TW; Carruthers NI Bioorg Med Chem Lett; 2007 Oct; 17(19):5325-9. PubMed ID: 17765543 [TBL] [Abstract][Full Text] [Related]
51. Histamine H3 receptor antagonists: from target identification to drug leads. Bonaventure P; Letavic M; Dugovic C; Wilson S; Aluisio L; Pudiak C; Lord B; Mazur C; Kamme F; Nishino S; Carruthers N; Lovenberg T Biochem Pharmacol; 2007 Apr; 73(8):1084-96. PubMed ID: 17129577 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of [18F]VUF 5000 as a potential PET ligand for brain imaging of the histamine H3 receptor. Windhorst AD; Timmerman H; Klok RP; Menge WM; Leurs R; Herscheid JD Bioorg Med Chem; 1999 Sep; 7(9):1761-7. PubMed ID: 10530922 [TBL] [Abstract][Full Text] [Related]
55. Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function. Yan Y; Scott DJ; Wilkinson TN; Ji J; Tregear GW; Bathgate RA Biochemistry; 2008 Jul; 47(26):6953-68. PubMed ID: 18533687 [TBL] [Abstract][Full Text] [Related]
56. Purification of the extracellular domain of the membrane protein GlialCAM expressed in HEK and CHO cells and comparison of the glycosylation. Gaudry JP; Arod C; Sauvage C; Busso S; Dupraz P; Pankiewicz R; Antonsson B Protein Expr Purif; 2008 Mar; 58(1):94-102. PubMed ID: 18082421 [TBL] [Abstract][Full Text] [Related]
57. Achievement of behavioral efficacy and improved potency in new heterocyclic analogs of benzofuran H3 antagonists. Cowart M; Faghih R; Gfesser G; Curtis M; Sun M; Zhao C; Bennani Y; Wetter J; Marsh K; Miller TR; Krueger K; Pan JB; Drescher K; Fox GB; Esbenshade TA; Hancock AA Inflamm Res; 2005 Apr; 54 Suppl 1():S25-6. PubMed ID: 15928820 [No Abstract] [Full Text] [Related]
58. 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists. Wijtmans M; Celanire S; Snip E; Gillard MR; Gelens E; Collart PP; Venhuis BJ; Christophe B; Hulscher S; van der Goot H; Lebon F; Timmerman H; Bakker RA; Lallemand BI; Leurs R; Talaga PE; de Esch IJ J Med Chem; 2008 May; 51(10):2944-53. PubMed ID: 18433114 [TBL] [Abstract][Full Text] [Related]